- Differential Diagnosis
- Try building your search one term at a time, and be as specific as you can! Search term example: "chronic cough".
- Do not enter multiple findings such as "anemia, chronic cough, weight loss, vomiting" all at the same time.
- After selecting your term from the search results a list of possible diagnoses will be generated. If the list is too long, you will be able to narrow it down by entering additional terms.
- Do not enter values such as "heart rhythm 110" or "sodium 125", instead use "tachycardia" or "hyponatremia".
Drug Information for 5% Dextrose inLactated Ringer's Injection (B. Braun Medical Inc.): DESCRIPTION
- CLINICAL PHARMACOLOGY
- INDICATIONS AND USAGE
- ADVERSE REACTIONS
- DOSAGE AND ADMINISTRATION
- HOW SUPPLIED
- External Links Related to 5% Dextrose inLactated Ringer's Injection (B. Braun Medical Inc.)
Each 100 mL of 5% Dextrose in Lactated Ringer's Injection contains: Hydrous Dextrose USP 5 g; Sodium Chloride USP 0.6 gSodium Lactate 0.31 g; Potassium Chloride USP 0.03 gCalcium Chloride Dihydrate USP 0.02 gWater for Injection USP qs
pH adjusted with Hydrochloric Acid NFpH: 4.6 (4.0–6.0) Calories per liter: 170Calculated Osmolarity: 530 mOsmol/liter, hypertonic
Concentration of Electrolytes (mEq/liter): Sodium 130 Potassium 4Calcium 3 Chloride 112 Lactate (CH3CH(OH) COO−) 28
5% Dextrose in Lactated Ringer's Injection is sterile, nonpyrogenic and contains no bacteriostatic or antimicrobial agents. This product is intended for intravenous administration.
The formulas of the active ingredients are:
Ingredients Molecular Formula Molecular Weight Sodium Chloride USP NaCl 58.44 Sodium Lactate CH3CH(OH) COONa 112.06 Potassium Chloride USP KCl 74.55 Calcium Chloride Dihydrate USP CaCl2•2H2O 147.02 Hydrous Dextrose USP 198.17
The EXCEL Container is Latex-free, PVC-free, and DEHP-free.
The plastic container is made from a multilayered film specifically developed for parenteral drugs. It contains no plasticizers and exhibits virtually no leachables. The solution contact layer is a rubberized copolymer of ethylene and propylene. The container is nontoxic and biologically inert. The container-solution unit is a closed system and is not dependent upon entry of external air during administration. The container is overwrapped to provide protection from the physical environment and to provide an additional moisture barrier when necessary.
Addition of medication should be accomplished using complete aseptic technique.
The closure system has two ports; the one for the administration set has a tamper evident plastic protector and the other is a medication addition site. Refer to the Directions for Use of the container.
- Drug Information Provided by National Library of Medicine (NLM).